×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALEC – alector, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALEC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
6/13
04:30 pm
alec
Alector Provides Executive Leadership Update [Yahoo! Finance]
Low
Report
Alector Provides Executive Leadership Update [Yahoo! Finance]
6/13
04:05 pm
alec
Alector Provides Executive Leadership Update
Low
Report
Alector Provides Executive Leadership Update
6/3
08:00 am
alec
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
Low
Report
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
5/9
01:23 pm
alec
Alector, Inc. (NASDAQ: ALEC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
Medium
Report
Alector, Inc. (NASDAQ: ALEC) had its price target raised by analysts at HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.
5/8
04:05 pm
alec
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
High
Report
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
5/6
08:00 am
alec
Alector to Participate in Upcoming Healthcare Conferences
High
Report
Alector to Participate in Upcoming Healthcare Conferences
4/17
08:00 am
alec
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
High
Report
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
3/28
04:05 pm
alec
Alector Provides Executive Leadership Update
Medium
Report
Alector Provides Executive Leadership Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
6/13
04:06 pm
alec
Form 8-K Alector, Inc. For: Jun 09
Low
Report
Form 8-K Alector, Inc. For: Jun 09
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: SCHELLER RICHARD H
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: SCHELLER RICHARD H
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: Hammond Paula
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: Hammond Paula
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: DESOUZA ERROL B
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: DESOUZA ERROL B
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: Altmeyer Mark
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: Altmeyer Mark
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: GAROFALO ELIZABETH A.
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: GAROFALO ELIZABETH A.
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: LAVIGNE LOUIS J JR
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: LAVIGNE LOUIS J JR
6/12
06:05 pm
alec
Form 4 Alector, Inc. For: Jun 11 Filed by: Yaffe Kristine
Medium
Report
Form 4 Alector, Inc. For: Jun 11 Filed by: Yaffe Kristine
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
2/5
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
12.0%
1/30 Form EFFECT Alector, Inc. 10.9%
1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%
4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%
4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%
2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%
5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%
3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%
9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%
12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%
1/30 Form EFFECT Alector, Inc. 10.9%
1/8 Alector to Present at the J.P. Morgan 38th Annual Healthcare Conference 10.0%
4/28 Alector Inc (NASDAQ: ALEC) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%
4/17 Form SC 13D/A Alector, Inc. Filed by: ORBIMED ADVISORS LLC 8.0%
2/3 Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 7.1%
5/13 Q1/2019 3/31/2019 EPS -0.420 ZacksConsensus N/A ActVsEst N/A - N/A 6.2%
3/25 Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China 5.5%
9/9 Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia 4.7%
12/11 Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer 4.3%
TOP News Decliners
3/30
Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC
-22.2%
2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%
3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%
3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%
2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%
4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%
4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%
12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%
3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%
1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%
2/7 Form 4 Alector, Inc. For: Feb 05 Filed by: Paul Robert -19.8%
3/23 Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors -18.8%
3/17 Alector Inc (NASDAQ: ALEC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $26.00 price target on the stock. -11.1%
2/24 Alector to Present at the Cowen 40th Annual Health Care Conference -11.0%
4/2 Form 4 Alector, Inc. For: Mar 31 Filed by: ORBIMED ADVISORS LLC -8.8%
4/9 Form 144 Alector, Inc. Filed by: ORBIMED ADVISORS LLC -8.0%
12/8 Alector Inc (NASDAQ: ALEC) had its "buy" rating re-affirmed by analysts at Cowen Inc. -6.2%
3/4 Form 4 Alector, Inc. For: Mar 02 Filed by: OrbiMed Capital GP IV LLC -6.0%
1/27 Alector Announces Proposed Public Offering of Common Stock -5.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: